Access cutting-edge opioid addiction treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Newark location
Access opioid addiction specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related opioid addiction treatment provided free
Check if you qualify for this opioid addiction clinical trial in Newark, NJ
No-Cost Study Care
Local to Newark
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This project, involving two distinct clinical trials, tests whether induction to a higher than currently recommended buprenorphine (BUP) induction dose is safe and can improve the proportion of patients who engage in comprehensive addiction services within 7-day of induction. Trial 1 is a head-to-head comparison of the safety, tolerability and feasibility of high dose BUP induction (32 mg). The study involves two cohorts, (1) a 12mg cohort (standard) to determine baseline data and (2) a 32 mg (
Sponsor: Rutgers, The State University of New Jersey
Yes, this clinical trial (NCT05589181) has an active research site in Newark, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for opioid addiction treatment options in Newark, NJ, this clinical trial (NCT05589181) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid addiction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all opioid addiction clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Newark — not just this study.
Browse Alzheimers Disease Trials in Newark →